Garda Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,343
Closed -$205K 249
2025
Q2
$205K Buy
+1,343
New +$206K ﹤0.01% 540
2024
Q1
Sell
-7,735
Closed -$1.21M 497
2023
Q4
$1.21M Sell
7,735
-3,778
-33% -$579K 0.1% 210
2023
Q3
$1.79M Buy
+11,513
New +$1.9M 0.08% 247
2023
Q2
Sell
-5,418
Closed -$874K 410
2023
Q1
$840K Buy
+5,418
New +$875K 0.04% 256

Other funds holding JNJ

Garda Capital Partners's JNJ Position: Q3 2025 in Review

Garda Capital Partners sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 1,343 shares — an estimated $205K sold.

Garda Capital Partners first reported a position in JNJ in Q1 2023 and held it in 4 quarters. The position peaked at $1.79M in Q3 2023. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Garda Capital Partners reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • Garda Capital Partners sold 1,343 Johnson & Johnson shares in Q3 2025, an estimated $205K.
  • Garda Capital Partners first reported a position in Johnson & Johnson in Q1 2023 and held it in 4 quarters.
  • Garda Capital Partners's Johnson & Johnson position peaked at $1.79M in Q3 2023.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Garda Capital Partners's 13F filing for Q3 2025, filed 10 Nov 2025.